Alzheimer's Disease Clinical Trials - Disability Videos
Links shared publicly online about this topic.
- 314total visits
Alzheimer's Disease Clinical Trials - Disability Videos
View full resource at videos.disabled-world.com
Tags: Alzheimer's Disease, Disease and Condition, Clinical Trial, Disability, disease
Most Recently Shared on May 5, 2011 at 10:13 pm By:
Alzheimer's Disease Clinical Trials http://ff.im/-CJK1J
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on March 24, 2012 at 12:00 am By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease: Conditio... http://t.co/THtuTBwi
Clinical trial fails to find antioxidant Alzheimer’s benefit
nutraingredients-usa.com — “Supplementation with an antioxidant-rich combination of vitamin E, vitamin C and alpha-lipoic acid (ALA) is not associated with changes in important markers for Alzheimer’s disease, finds new research.” View full resource at nutraingredients-usa.com
Most Recently Shared on March 21, 2012 at 5:26 pm By:
Clinical trial fails to find antioxidant Alzheimer’s benefit: The randomized controlled trial – published in JAM... http://t.co/ASluPF9M
Alzheimer's Association awards $4.2M grant to DIAN-Therapeutic Trials Unit
news-medical.net — “Washington University School of Medicine in St. Louis has received nearly $4.2 million from the Alzheimer's Association to accelerate the launch of the first clinical trials to prevent the symptoms of Alzheimer's disease.” View full resource at news-medical.net
Most Recently Shared on March 21, 2012 at 10:25 am By:
Alzheimer's Association awards $4.2M grant to DIAN-Therapeutic Trials Unit: Washington University School of Medi... http://t.co/TD9nS8b9
Alzheimer's Association awards $4.2M grant to DIAN-Therapeutic Trials Unit | Tibidy Health | Joeygiggles Health Topics | Scoop.it
scoop.it — “Washington University School of Medicine in St. Louis has received nearly $4.2 million from the Alzheimer's Association to accelerate the launch of the first clinical trials to prevent the symptoms of Alzheimer's disease.” View full resource at scoop.it
Most Recently Shared on March 21, 2012 at 7:00 am By:
Alzheimer's Association awards $4.2M grant to DIAN-Therapeutic Trials Unit | Tibidy Health | @scoopit via @TibidyHealth http://t.co/vO9d9MRK
$4.2 million grant helps plan, launch first Alzheimer's prevention trials
eurekalert.org — “Washington University School of Medicine in St. Louis has received nearly $4.2 million from the Alzheimer's Association to accelerate the launch of the first clinical trials to prevent the symptoms of Alzheimer's disease. The award is the largest research grant in the history of the 32-year-old association.” View full resource at eurekalert.org
Most Recently Shared on March 20, 2012 at 10:24 pm By:
$4.2 million grant helps plan, launch first Alzheimer's prevention trials: ( Washington University School of Med... http://t.co/jf5KwNn3
Arch Neurol -- Abstract: Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures, March 19, 2012, Galasko et al. 0 (2012): archneurol.2012.85v1
archneur.ama-assn.org — “Archives of Neurology, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed scientific research on the nervous system” View full resource at archneur.ama-assn.org
Most Recently Shared on March 20, 2012 at 3:16 pm By:
#Antioxidants not associated with changes in cerebrospinal fluid biomarkers for #Alzheimer disease http://t.co/ud8ckXsy #neurology
Clinical Trial Examining Effects of Antioxidants for Alzheimer Disease on Cerebrospinal Fluid Biomarkers | Biomarker Commons
biomarkercommons.org — “An antioxidant combination of vitamin E, vitamin C and alpha-lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease in a randomized controlled trial, according to a study published Online First by Archives of Neurology, one of the JAMA/Archives journals.” View full resource at biomarkercommons.org
Most Recently Shared on March 20, 2012 at 1:59 pm By:
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers
sciencedaily.com — “An antioxidant combination of vitamin E, vitamin C and alpha-lipoic acid was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer's disease in a randomized controlled trial, according to a new study.” View full resource at sciencedaily.com
Most Recently Shared on March 20, 2012 at 10:22 am By:
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers: An antiox... http://t.co/0cyj8frQ
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers
eurekalert.org — “An antioxidant combination of vitamin E, vitamin C and alpha-lipoic acid was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer's disease in a randomized controlled trial, according to a study published online first by Archives of Neurology, one of the JAMA/Archives journals.” View full resource at eurekalert.org
Most Recently Shared on March 19, 2012 at 11:20 pm By:
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers: An antiox... http://t.co/BvRbP3G0
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers
medicalxpress.com — “An antioxidant combination of vitamin E, vitamin C and α-lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease in a randomized controlled trial, according to a study published Online First by Archives of Neurology.” View full resource at medicalxpress.com
Most Recently Shared on March 19, 2012 at 7:57 pm By:
PhysOrg Health News Health News
Clinical trial examines antioxidant effects for Alzheimer's disease on cerebrospinal fluid biomarkers http://t.co/TvhddhWN
Cancer drug improves memory in mouse model of Alzheimer's disease
eurekalert.org — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 issue of the Journal of Neuroscience. The findings suggest the drug epothilone D may one day prove useful for treating people with early-stage Alzheimer's disease.” View full resource at eurekalert.org
Most Recently Shared on March 14, 2012 at 4:10 pm By:
Cancer drug improves memory in mouse model of Alzheimer's disease: (Society for Neuroscience) A compound that pr... http://t.co/00DESYZJ
Alzheimer's Mice Treated With Cancer Drug Show Improved Memory
medicalnewstoday.com — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to” View full resource at medicalnewstoday.com
Most Recently Shared on March 14, 2012 at 10:05 am By:
MNT Alzheimer's News Health News
Alzheimer's Mice Treated With Cancer Drug Show Improved Memory http://t.co/51Ti3dpv #alzheimers
Potential Alzheimer's disease drug slows damage and symptoms in animal model
sciencedaily.com — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a new study. The compound epothilone D is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease (AD). The results establish how the drug might be used in early-stage AD patients.” View full resource at sciencedaily.com
Most Recently Shared on March 14, 2012 at 3:52 am By:
Potential Alzheimer's disease drug slows damage and symptoms in animal model: A compound that previously progres... http://t.co/feX2ARxC
Cancer drug improves memory in mouse model of Alzheimer's disease
medicalxpress.com — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 issue of The Journal of Neuroscience. The findings suggest the drug epothilone ...” View full resource at medicalxpress.com
Most Recently Shared on March 13, 2012 at 8:57 pm By:
PhysOrg Health News Health News
Cancer drug improves memory in mouse model of Alzheimer's disease http://t.co/oy1uEqqR
JAK-STAT inhibitors reverse MS-like disease in mice
news-medical.net — “A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.” View full resource at news-medical.net
Most Recently Shared on March 13, 2012 at 6:05 am By:
JAK-STAT inhibitors reverse MS-like disease in mice: A new class of drugs completing clinical trials soon for rh... http://t.co/VNwZIqB3
Advertisement
